Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Stip

Showing results (221-230 of 278) with videos related to

Pageof 28
Sort By:
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 18, 2024
Clinical Reasoning in the Use of Long-acting Aripiprazole in Psychosis in Bilateral Nephrectomy on HemodialysisKarim Abdel Aziz, Aysha Alhashmi, Omar Bin Abdul Aziz, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 26, 2025
Assessment of cognitive domains in major depressive disorders using the Cambridge Neuropsychological Test Automated Battery (CANTAB): Systematic review and meta-analysis of cross-sectional and longitudinal studiesDanilo Arnone, Reshma Ramaraj, Linda Östlundh, et al.
Psychiatry Research|November 28, 2006
Use of the process dissociation procedure to study the contextual effects on face recognition in schizophrenia: familiarity, associative recollection and discriminative recollectionFabrice Guillaume, François Guillem, Guy Tiberghien, et al.
Acta Psychiatrica Scandinavica|February 14, 2022
Comparative effectiveness and safety of antipsychotic drugs in patients with schizophrenia initiating or reinitiating treatment: A Real-World Observational StudySébastien Brodeur, Alain Vanasse, Josiane Courteau, et al.
Addiction (Abingdon, England)|January 19, 2021
Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo-controlled trialViolaine Mongeau-Pérusse, Suzanne Brissette, Julie Bruneau, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2010
Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophreniaSimon Zhornitsky, Emmanuel Stip, Tania Pampoulova, et al.
Schizophrenia Research|April 10, 2025
Hippocampus subfield volume reductions in treatment-resistant schizophreniaAlexandra Fortier, Andràs Tikàsz, Maria Athanassiou, et al.
Schizophrenia (Heidelberg, Germany)|July 19, 2022
Multidimensional analysis of adult patients' care trajectories before a first diagnosis of schizophreniaAlain Vanasse, Josiane Courteau, Mireille Courteau, et al.
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology|June 24, 2004
Procedural learning in schizophrenia can reflect the pharmacologic properties of the antipsychotic treatmentsHélène Scherer, Marc-André Bedard, Emmanuel Stip, et al.
Community Mental Health Journal|August 1, 2012
Predictors of community functioning in schizophrenia and substance use disorder patientsSimon Zhornitsky, Ginette Aubin, Joelle Desfossés, et al.
Pageof 28

Showing results (221-230 of 278) with videos related to

Sort By:
Pageof 28
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 18, 2024
Clinical Reasoning in the Use of Long-acting Aripiprazole in Psychosis in Bilateral Nephrectomy on HemodialysisKarim Abdel Aziz, Aysha Alhashmi, Omar Bin Abdul Aziz, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 26, 2025
Assessment of cognitive domains in major depressive disorders using the Cambridge Neuropsychological Test Automated Battery (CANTAB): Systematic review and meta-analysis of cross-sectional and longitudinal studiesDanilo Arnone, Reshma Ramaraj, Linda Östlundh, et al.
Psychiatry Research|November 28, 2006
Use of the process dissociation procedure to study the contextual effects on face recognition in schizophrenia: familiarity, associative recollection and discriminative recollectionFabrice Guillaume, François Guillem, Guy Tiberghien, et al.
Acta Psychiatrica Scandinavica|February 14, 2022
Comparative effectiveness and safety of antipsychotic drugs in patients with schizophrenia initiating or reinitiating treatment: A Real-World Observational StudySébastien Brodeur, Alain Vanasse, Josiane Courteau, et al.
Addiction (Abingdon, England)|January 19, 2021
Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo-controlled trialViolaine Mongeau-Pérusse, Suzanne Brissette, Julie Bruneau, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2010
Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophreniaSimon Zhornitsky, Emmanuel Stip, Tania Pampoulova, et al.
Schizophrenia Research|April 10, 2025
Hippocampus subfield volume reductions in treatment-resistant schizophreniaAlexandra Fortier, Andràs Tikàsz, Maria Athanassiou, et al.
Schizophrenia (Heidelberg, Germany)|July 19, 2022
Multidimensional analysis of adult patients' care trajectories before a first diagnosis of schizophreniaAlain Vanasse, Josiane Courteau, Mireille Courteau, et al.
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology|June 24, 2004
Procedural learning in schizophrenia can reflect the pharmacologic properties of the antipsychotic treatmentsHélène Scherer, Marc-André Bedard, Emmanuel Stip, et al.
Community Mental Health Journal|August 1, 2012
Predictors of community functioning in schizophrenia and substance use disorder patientsSimon Zhornitsky, Ginette Aubin, Joelle Desfossés, et al.
Pageof 28